The Food and Drug Administration wants to make it easier for some common medicines to be sold without a prescription. The agency proposed new guidelines Tuesday for drugmakers
TOKYO and NEW YORK, July 13, 2018 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) today announced
The FDA decision comes a week after 22 other countries imposed similar recalls. A week after 22 countries recalled drugs used to treat high blood pressure and assist
July 13, 2018 — The U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health
The U.S. Food and Drug Administration has approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause anxiety. Dermira Inc. said Friday
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
